A detailed history of Eagle Wealth Strategies LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Eagle Wealth Strategies LLC holds 4,000 shares of EXAS stock, worth $232,440. This represents 0.2% of its overall portfolio holdings.

Number of Shares
4,000
Holding current value
$232,440
% of portfolio
0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$42.43 - $70.83 $169,720 - $283,320
4,000 New
4,000 $272 Million
Q4 2023

Feb 05, 2024

BUY
$59.06 - $75.72 $236,240 - $302,880
4,000 New
4,000 $296 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Eagle Wealth Strategies LLC Portfolio

Follow Eagle Wealth Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Wealth Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Wealth Strategies LLC with notifications on news.